MIM
HRT

MetLife Investment Management’s HireRight Holdings Corporation HRT Stock Holding History

MetLife Investment Management’s Portfolio HRT Stock Details HRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,503
Closed -$121K – 2937
2024
Q1 		$121K Hold
8,503
– – ﹤0.01% 2449
2023
Q4 		$114K Hold
8,503
– – ﹤0.01% 2539
2023
Q3 		$80.9K Hold
8,503
– – ﹤0.01% 2688
2023
Q2 		$96.2K Sell
8,503
-6,930
-45% -$72.7K ﹤0.01% 2705
2023
Q1 		$164K Hold
15,433
– – ﹤0.01% 2343
2022
Q4 		$183K Hold
15,433
– – ﹤0.01% 2300
2022
Q3 		$236K Hold
15,433
– – ﹤0.01% 2185
2022
Q2 		$219K Hold
15,433
– – ﹤0.01% 2252
2022
Q1 		$264K Buy
15,433
+5,503
+55% +$74.1K ﹤0.01% 2176
2021
Q4 		$159K Buy
+9,930
New +$166K ﹤0.01% 2196

Other funds holding HRT

AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

MetLife Investment Management's HRT Position: Q2 2024 in Review

MetLife Investment Management sold out of HireRight Holdings Corporation (HRT) in Q2 2024, closing a stake of 8,503 shares — an estimated $121K sold.

MetLife Investment Management first reported a position in HRT in Q4 2021 and held it in 10 quarters. The position peaked at $264K in Q1 2022. 1 fund tracked by Wall St. Rank holds HRT as of Q2 2024.

  • MetLife Investment Management reported no remaining HireRight Holdings Corporation position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 8,503 HireRight Holdings Corporation shares in Q2 2024, an estimated $121K.
  • MetLife Investment Management first reported a position in HireRight Holdings Corporation in Q4 2021 and held it in 10 quarters.
  • MetLife Investment Management's HireRight Holdings Corporation position peaked at $264K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held HireRight Holdings Corporation as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.